13 enero 2015
A new protein-protein interaction that could serve as a target for future therapies for the most common form of brain cancer, glioblastoma multiforme (GBM), has been identified by researchers. GBM is a devastating disease that originates from glia or their precursors within the central nervous system, and the prognosis for GBM patients is unfortunately poor, but this discovery offers new therapeutic potential.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ws0EWzmOU-Y/150113121050.htm
